Mengmeng Liu
Shenzhen, 518109, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Prognostic Value of Double-expressor Phenotype and an Exploratory DEP-IPI Risk Model in Primary Testicular Diffuse Large B-cell Lymphoma: A Multicenter Retrospective Cohort Study.
Journal: Clinical genitourinary cancer
Published: June 10, 2026
Cost-effectiveness analysis of tepotinib vs capmatinib as subsequent therapy in MET exon 14-mutated non-small-cell lung cancer.
Journal: Lung cancer management
Published: April 04, 2026
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 06, 2026
Integrated Network Pharmacology, Molecular Docking, and Experimental Validation for Uncovering the Pharmacodynamic Basis of Sanghuang against Human Pulmonary Fibrosis.
Journal: Combinatorial chemistry & high throughput screening
Published: February 16, 2026
Discovery of co-stimulatory anti-CD28 VHHs for developing cancer immune therapeutic anti-tumor/CD3/CD28 trispecific T cell engager.
Journal: Frontiers in immunology
Published: February 16, 2026
Integrated Single-Cell Multi-Omics Analysis Reveals That a CD8+ TPex-Monocyte Interaction Axis Coordinates Immune Infiltration in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: December 11, 2025
Identification of Immune&Driver Molecular Subtypes Optimizes Immunotherapy Strategies for Gastric Cancer.
Journal: International journal of molecular sciences
Published: December 04, 2025
Cost-effectiveness analysis of Atezolizumab plus bevacizumab vs. Rivoceranib plus Camrelizumab as first-line treatment for unresectable hepatocellular carcinoma.
Journal: Frontiers in public health
Published: November 19, 2025
Corrigendum to "Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin" [Bioorg. Chem. 166 (2025) 109195].
Journal: Bioorganic chemistry
Published: November 16, 2025
Cost-effectiveness analysis of triplet therapy of encorafenib, binimetinib, and cetuximab for treatment of metastatic BRAF V600E-mutated colorectal cancer in China.
Journal: Frontiers in pharmacology
Published: November 14, 2025
Hepatic stellate cell enriched Asporin drives liver fibrosis by stabilizing ERH to promote IL-17/MAPK11 signaling.
Journal: Acta pharmaceutica Sinica. B
Published: September 11, 2025
Last Updated: 09/26/2026